Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Oncology: GI

  • You have access
    18F-Fluorodihydroxyphenylalanine PET/CT at the Forefront for Initial and/or Pre-surgical Evaluation of Small Intestine Neuroendocrine Tumors
    Eric Ouvrard, Louis De Mestier, Caroline Boursier, Boumediene Lachachi, Nicolas Sahakian, Elodie Chevalier, Nidaa Mikail, Josefina Carullo, Aurélie Bando-Delaunay, Thomas Walter, Gabriel G. Malouf, Pietro Addeo, Gilles Poncet, Frederic Sebag, Rachida Lebtahi, Bernard Goichot, David Taïeb and Alessio Imperiale
    Journal of Nuclear Medicine May 19, 2022, jnumed.122.263984; DOI: https://doi.org/10.2967/jnumed.122.263984
  • You have access
    Dual-tracer PET/CT protocol with [18F]-FDG and [68Ga]Ga-FAPI-46 for cancer imaging - a proof of concept.
    Katrin S Roth, Conrad-Amadeus Voltin, Lutz van-Heek, Simone Wegen, Klaus Schomaecker, Thomas Fischer, Simone Marnitz, Alexander E. Drzezga and Carsten Kobe
    Journal of Nuclear Medicine April 14, 2022, jnumed.122.263835; DOI: https://doi.org/10.2967/jnumed.122.263835
  • You have access
    Targeted Alpha-Emitter Therapy With 212Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Human, Dose-Escalation Clinical Trial
    Ebrahim S Delpassand, Izabela Tworowska, Rouzbeh Esfandiari, Julien Torgue, Jason Hurt, Afshin Shafie and Rodolfo Núñez
    Journal of Nuclear Medicine January 6, 2022, jnumed.121.263230; DOI: https://doi.org/10.2967/jnumed.121.263230
  • You have access
    The quest for an accurate functional tumor volume with 68Ga-DOTATATE PET/CT
    Ryan P Reddy, C Ross Schmidtlein, Romina G Giancipoli, Audre Mauguen, Daniel LaFontaine, Heiko Schoder and Lisa Bodei
    Journal of Nuclear Medicine November 12, 2021, jnumed.121.262782; DOI: https://doi.org/10.2967/jnumed.121.262782
  • You have access
    Glypican-3 targeted thorium-227 alpha therapy reduces tumor burden in an orthotopic xenograft murine model of hepatocellular carcinoma
    Kevin P Labadie, Donald K Hamlin, Aimee Kenoyer, Sara K Daniel, Alan F Utria, Andrew D Ludwig, Heidi L Kenerson, Lily Li, Jonathan G Sham, Delphine L Chen, Johnnie J Orozco, Raymond S Yeung, Chris Orvig, Yawen Li, D Scott Wilbur and James O Park
    Journal of Nuclear Medicine November 12, 2021, jnumed.121.262562; DOI: https://doi.org/10.2967/jnumed.121.262562
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire